Dermatite allergica da contatto delle palpebre da topici oftalmici. Il ruolo dei β-bloccanti: Problemi di diagnosi e gestione

Translated title of the contribution: Allergic contact dermatitis of the eyelids from topical ophthalmic medications. The role of β-blockers: Diagnostic and management problems

Massimiliano Nino, Nicola Balato, Fabrizio Ayala, Fabio Ayala

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Background: β-blockers, i.e. β-adrenergic receptors antagonists, are drugs which are widely used in local medications for the treatment of open-angle glaucoma. Allergic contact dermatitis (ACD) due to the β-blockers contained in eyedrops are rare, but it can be difficult for dermatologists to diagnose and manage because of the low sensitivity to patch tests with such drugs and of the possible cross-reactions between them. Materials and methods: in four glaucoma patients with signs of eczema on their eyelids (in two cases conjunctivitis was also present) patch tests were carried out using haptens of the SIDAPA standard series, of a palpebral series and from our series of vehicles and preservatives. Moreover, we tested the eyedrops' components and another series containing β-blockers that the patients had never used before. Results: all patients reported positive reactions to patch tests containing the suspected β-blockers. Moreover, in two of these patients reactions to β-blockers that were never used before were observed. Conclusions: The diagnosis and management of patients with ACD caused by eye medications containing β-blockers can be difficult: in fact patch tests used with commercial ophthalmic medications are not sensitive enough and we lack a standardized pattern of skin tests with greater diagnostic efficacy. We suggest patch testing on the classical sites (back or forearm) at a higher concentration than those contained, at present, in the ophthalmic products available on the market. If the tests are negative, it is advisable to carry out modified skin tests, such as a scratch test, to stimulate greater absorption by the palpebral skin. Moreover, it is also advisable to test all patients with a series of alternative β-blockers in order to discover possible cross-reactions, as well as testing alternative medications.

Original languageItalian
Pages (from-to)18-22
Number of pages5
JournalAnnali Italiani di Dermatologia Allergologica Clinica e Sperimentale
Volume61
Issue number1
Publication statusPublished - Jan 2007

Fingerprint

Allergic Contact Dermatitis
Eyelids
Patch Tests
Ophthalmic Solutions
Cross Reactions
Skin Tests
Skin Absorption
Adrenergic Antagonists
Conjunctivitis
Haptens
Open Angle Glaucoma
Eczema
Forearm
Pharmaceutical Preparations
Glaucoma

ASJC Scopus subject areas

  • Dermatology

Cite this

Dermatite allergica da contatto delle palpebre da topici oftalmici. Il ruolo dei β-bloccanti : Problemi di diagnosi e gestione. / Nino, Massimiliano; Balato, Nicola; Ayala, Fabrizio; Ayala, Fabio.

In: Annali Italiani di Dermatologia Allergologica Clinica e Sperimentale, Vol. 61, No. 1, 01.2007, p. 18-22.

Research output: Contribution to journalArticle

@article{21a3d0daa11142ef82fe387c1ff7560f,
title = "Dermatite allergica da contatto delle palpebre da topici oftalmici. Il ruolo dei β-bloccanti: Problemi di diagnosi e gestione",
abstract = "Background: β-blockers, i.e. β-adrenergic receptors antagonists, are drugs which are widely used in local medications for the treatment of open-angle glaucoma. Allergic contact dermatitis (ACD) due to the β-blockers contained in eyedrops are rare, but it can be difficult for dermatologists to diagnose and manage because of the low sensitivity to patch tests with such drugs and of the possible cross-reactions between them. Materials and methods: in four glaucoma patients with signs of eczema on their eyelids (in two cases conjunctivitis was also present) patch tests were carried out using haptens of the SIDAPA standard series, of a palpebral series and from our series of vehicles and preservatives. Moreover, we tested the eyedrops' components and another series containing β-blockers that the patients had never used before. Results: all patients reported positive reactions to patch tests containing the suspected β-blockers. Moreover, in two of these patients reactions to β-blockers that were never used before were observed. Conclusions: The diagnosis and management of patients with ACD caused by eye medications containing β-blockers can be difficult: in fact patch tests used with commercial ophthalmic medications are not sensitive enough and we lack a standardized pattern of skin tests with greater diagnostic efficacy. We suggest patch testing on the classical sites (back or forearm) at a higher concentration than those contained, at present, in the ophthalmic products available on the market. If the tests are negative, it is advisable to carry out modified skin tests, such as a scratch test, to stimulate greater absorption by the palpebral skin. Moreover, it is also advisable to test all patients with a series of alternative β-blockers in order to discover possible cross-reactions, as well as testing alternative medications.",
keywords = "β-blockers, Contact dermatitis, Cross-reactions, Ophthalmic medications, Patch test, Use test",
author = "Massimiliano Nino and Nicola Balato and Fabrizio Ayala and Fabio Ayala",
year = "2007",
month = "1",
language = "Italian",
volume = "61",
pages = "18--22",
journal = "Annali Italiani di Dermatologia Allergologica Clinica e Sperimentale",
issn = "1592-6826",
publisher = "Il Pensiero Scientifico Editore s.r.l.",
number = "1",

}

TY - JOUR

T1 - Dermatite allergica da contatto delle palpebre da topici oftalmici. Il ruolo dei β-bloccanti

T2 - Problemi di diagnosi e gestione

AU - Nino, Massimiliano

AU - Balato, Nicola

AU - Ayala, Fabrizio

AU - Ayala, Fabio

PY - 2007/1

Y1 - 2007/1

N2 - Background: β-blockers, i.e. β-adrenergic receptors antagonists, are drugs which are widely used in local medications for the treatment of open-angle glaucoma. Allergic contact dermatitis (ACD) due to the β-blockers contained in eyedrops are rare, but it can be difficult for dermatologists to diagnose and manage because of the low sensitivity to patch tests with such drugs and of the possible cross-reactions between them. Materials and methods: in four glaucoma patients with signs of eczema on their eyelids (in two cases conjunctivitis was also present) patch tests were carried out using haptens of the SIDAPA standard series, of a palpebral series and from our series of vehicles and preservatives. Moreover, we tested the eyedrops' components and another series containing β-blockers that the patients had never used before. Results: all patients reported positive reactions to patch tests containing the suspected β-blockers. Moreover, in two of these patients reactions to β-blockers that were never used before were observed. Conclusions: The diagnosis and management of patients with ACD caused by eye medications containing β-blockers can be difficult: in fact patch tests used with commercial ophthalmic medications are not sensitive enough and we lack a standardized pattern of skin tests with greater diagnostic efficacy. We suggest patch testing on the classical sites (back or forearm) at a higher concentration than those contained, at present, in the ophthalmic products available on the market. If the tests are negative, it is advisable to carry out modified skin tests, such as a scratch test, to stimulate greater absorption by the palpebral skin. Moreover, it is also advisable to test all patients with a series of alternative β-blockers in order to discover possible cross-reactions, as well as testing alternative medications.

AB - Background: β-blockers, i.e. β-adrenergic receptors antagonists, are drugs which are widely used in local medications for the treatment of open-angle glaucoma. Allergic contact dermatitis (ACD) due to the β-blockers contained in eyedrops are rare, but it can be difficult for dermatologists to diagnose and manage because of the low sensitivity to patch tests with such drugs and of the possible cross-reactions between them. Materials and methods: in four glaucoma patients with signs of eczema on their eyelids (in two cases conjunctivitis was also present) patch tests were carried out using haptens of the SIDAPA standard series, of a palpebral series and from our series of vehicles and preservatives. Moreover, we tested the eyedrops' components and another series containing β-blockers that the patients had never used before. Results: all patients reported positive reactions to patch tests containing the suspected β-blockers. Moreover, in two of these patients reactions to β-blockers that were never used before were observed. Conclusions: The diagnosis and management of patients with ACD caused by eye medications containing β-blockers can be difficult: in fact patch tests used with commercial ophthalmic medications are not sensitive enough and we lack a standardized pattern of skin tests with greater diagnostic efficacy. We suggest patch testing on the classical sites (back or forearm) at a higher concentration than those contained, at present, in the ophthalmic products available on the market. If the tests are negative, it is advisable to carry out modified skin tests, such as a scratch test, to stimulate greater absorption by the palpebral skin. Moreover, it is also advisable to test all patients with a series of alternative β-blockers in order to discover possible cross-reactions, as well as testing alternative medications.

KW - β-blockers

KW - Contact dermatitis

KW - Cross-reactions

KW - Ophthalmic medications

KW - Patch test

KW - Use test

UR - http://www.scopus.com/inward/record.url?scp=34250786957&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34250786957&partnerID=8YFLogxK

M3 - Articolo

AN - SCOPUS:34250786957

VL - 61

SP - 18

EP - 22

JO - Annali Italiani di Dermatologia Allergologica Clinica e Sperimentale

JF - Annali Italiani di Dermatologia Allergologica Clinica e Sperimentale

SN - 1592-6826

IS - 1

ER -